(Q57655200)

English

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation

No description defined

In more languages

Statements

scholarly article

0 references

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation (English)

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

author name string

Q A Hill

1

0 references

A Hill

2

0 references

T A Collyns

3

0 references

R M Pearce

4

0 references

G Cook

5

0 references

language of work or name

0 references

publication date

14 January 2008

0 references

Bone Marrow Transplantation

0 references

41

0 references

8

0 references

749-751

0 references

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705974

0 references

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of CAMPATH-1H in BMT patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705974

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57655200&oldid=1829714163"